A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: An empirical examination of the status of empirically supported therapies

Journal of Consulting and Clinical Psychology

Volumn 69, Issue 6, 2001, Pages 875-899

  Westen, Drew ^a   Morrison, Kate ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; DEPRESSION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; OUTCOMES RESEARCH; PANIC; PSYCHOTHERAPY; SCREENING;

EID: 0035210498     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.69.6.875     Document Type: Article

References (136)

1. Outcome predictors for the cognitive behavior treatment of bulimia nervosa: Data from a multisite study
2. Training in and dissemination of empirically-validated psychological treatments: Report and recommendations
3. Psychological treatments of panic disorder without agoraphobia: Cognitive therapy versus applied relaxation
4. Cognitivebehavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial
5. Behavioral treatment of generalized anxiety disorder
6. Treating depression in the context of marital discord: Outcome and predictors of response to marital therapy versus cognitive therapy
7. A crossover study of focused cognitive therapy for panic disorder
8. Comparison of cognitive therapy and relaxation training for panic disorder
9. An inventory for measuring depression
10. Predictors of differential response to cognitive, experiential, and self-directed psychotherapeutic procedures
11. Mechanisms of change in the treatment of panic
12. Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder
13. What is the scientific meaning of empirically supported therapy?
14. Exposure versus cognitive restructuring in the treatment of panic disorder with agoraphobia
15. Efficacy of self-examination therapy in the treatment of generalized anxiety disorder
16. The efficacy of self-examination therapy and cognitive bibliotherapy in the treatment of mild to moderate depression
17. Long-term outcome in cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment
18. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal
19. Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: A long-term follow-up of the Peoria and Dartmouth studies
20. Comparison of behavior therapy and cognitive-behavior therapy in the treatment of generalized anxiety disorder
21. Empirically supported treatments: Implications for training
22. Convergent and discriminant validation by the multitrait-multimethod matrix
23. Defining empirically supported therapies
24. A preliminary study of African Americans with agoraphobia: Symptom severity and outcome of treatment with in vivo exposure
25. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder
26. Reduced therapist contact in the cognitive-behavioral treatment of panic disorder
27. Changes in fear versus avoidance ratings with behavioral treatments for agoraphobia
28. Behavioral treatment of panic disorder: A two-year follow-up
29. An open trial of brief supportive-expressive psychotherapy in the treatment of generalized anxiety disorder
30. The two disciplines of scientific psychology
31. Treatment of panic disorder with agoraphobia: Comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone
32. How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression
33. Medications versus cognitive behavior therapy for severely depressed outpatients: Meta-analysis of four randomized comparisons
34. Cognitive therapy, analytic psychotherapy and anxiety management training for generalised anxiety disorder
35. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program
36. Individual behavioural-cognitive therapy vs. marital therapy for depression in maritally distressed couples
37. Spouse-aided therapy with agoraphobics
38. Differential relapse following cognitive therapy and pharmacotherapy for depression
39. Long-term effects of behavioral treatment for panic disorder with agoraphobia
40. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims
41. Does a placebo tablet affect psychotherapeutic treatment outcome? Results from the Pittsburgh study of maintenance therapies in recurrent depression
42. Three-year outcomes for maintenance therapies in recurrent depression
43. Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression
44. Effectiveness of exposure and ritual prevention for obsessivecompulsive disorder: Randomized compared with nonrandomized samples
45. Maintenance of gains versus relapse following brief psychotherapy for depression
46. Psychotherapy practice and research: Repairing a strained alliance
47. Toward a clinically valid approach to therapy research
48. Randomized clinical trials in psychotherapy research: Methodology, design, and evaluation
49. The assessment of anxiety states by rating
50. Development of a rating scale for primary depressive illness
51. Credibility and outcome of cognitive-behavioural and psychodynamicinterpersonal therapy
52. Cognitive therapy and pharmacotherapy for depression
53. A phase model of psychotherapy: Causal mediation of outcome
54. Use of exclusion criteria in selecting research subjects and its effects on the generalizability of alcohol treatment outcome studies
55. The role of nonspecific factors in cognitive-behavior therapy for depression
56. Empirically supported treatments: A critical analysis
57. Marital therapy as treatment for depression
58. Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives
59. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research
60. The clinical course of unipolar major depressive disorders
61. Time to recovery, chronicity, and levels of psychopathology in major depression: A 5-year prospective follow-up of 431 subjects
62. Empirically supported psychological therapies
63. Therapy outcome research methods
64. Normative comparisons for the evaluation of clinical significance
65. Normative data for normative comparisons
66. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey
67. A comparison of alprazolam and behavior therapy in treatment of panic disorder
68. Patterns of symptomatic recovery in psychotherapy
69. Individual psychotherapy outcome and process research: Challenges leading to greater turmoil or a positive transition?
70. Factors in outcomes of short-term dynamic psychotherapy for chronic vs. nonchronic major depression
71. The researcher's own therapy allegiances: A "wild card" in comparisons of treatment efficacy
72. Alprazolam and exposure alone and combined in panic disorder with agoraphobia
73. Relative endurance of unipolar depression treatment effects: Longitudinal follow-up
74. Panic disorder: Cognitive-behavioral treatment
75. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up
76. Practice guidelines: Not yet ideal
77. Research on psychotherapy efficacy and effectiveness: Between Scylla and Charybdis?
78. The role of homework skill acquisition in the outcome of group cognitive therapy for depression
79. Comorbidity of Axis I and Axis II disorders
80. Marital therapy: A viable treatment for depression and marital discord
81. Applied relaxation vs cognitive-behavior therapy in the treatment of panic disorder
82. Applied relaxation, exposure in vivo and cognitive methods in the treatment of panic disorder with agoraphobia
83. Writing about emotional experiences as a therapeutic process
84. Are results of randomized controlled trials useful to psychotherapists?
85. Validity in the diagnosis of personality disorders: The use of the LEAD standard
86. A controlled comparison of cognitive-behaviour therapy, diazepam, and placebo, alone and in combination, for the treatment of generalized anxiety disorder
87. Comparative efficacy of religious and nonreligious cognitive-behavioral therapy for the treatment of clinical depression in religious individuals
88. A follow-up study on short-term treatment of agoraphobia
89. What works for whom?
90. Treating major depression in primary care practice
91. The effectiveness of psychotherapy
92. Effects of treatment duration and severity of depression on the effectiveness of cognitive-behavioral and psychodynamic-interpersonal psychotherapy
93. Two-year follow-up of the Sheffield psychotherapy project
94. Effects of treatment duration and severity of depression on the maintenance of gains after cognitive-behavioral and psycho-dynamic-interpersonal psychotherapy
95. Course of depressive symptoms over follow-up: Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program
96. Comorbidity of personality disorders and depression: Implications for treatment
97. Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder
98. Meta-analysis of psychotherapy outcome studies
99. Long-term effectiveness of behavioral versus insight-oriented marital therapy: A 4-year follow-up study
100. Toward greater public health relevance for psychotherapeutic intervention research: An NIMH workshop report
101. Effectiveness of an empirically based treatment for panic disorder delivered in a service clinic setting: 1-year follow-up
102. Sudden gains and critical sessions in cognitive-behavioral therapy for depression
103. Suffocation false alarms and efficacy of cognitive behavioral therapy for panic disorder
104. Group cognitive behavioral treatment of panic disorder
105. Impact of cognitive-behavioral treatment on quality of life in panic disorder patients
106. Cognitive behavior therapy of endogenous depression: II. Preliminary findings in 16 unmedicated inpatients
107. Do depressed men and women respond similarly to cognitive behavior therapy?
108. Response to cognitive-behavioral therapy in chronic depression
109. Cognitive behavior therapy and relapse of nonbipolar depression: Parallels with pharmacotherapy
110. Relapse after cognitive behavior therapy of depression: Potential implications for longer courses of treatment
111. Exposure reduced agoraphobia but not panic, and cognitive therapy reduced panic but not agoraphobia
112. Chronic life stress and treatment outcome in agoraphobia with panic attacks
113. A meta-analysis of outcome studies comparing bona fide psychotherapies: Empirically "all must have prizes."
114. The scientific legacy of Sigmund Freud. Toward a psychodynamically informed psychological science
115. Psychodynamic theory and technique in relation to research on cognition and emotion: Mutual implications
116. Limitations of axis II in diagnosing personality pathology in clinical practice
117. Methodological issues in research using projective techniques
118. Personality profiles in eating disorders: Rethinking the distinction between Axis I and Axis II
119. Cognitive therapy with depressed inpatients: Specific effects on dysfunctional cognitions
120. Hopelessness depression in depressed inpatients: Symptomatology, patient characteristics, and outcome
121. Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability
122. The emotional Stroop task and psychopathology
123. Rapid response to cognitive behavior therapy
124. Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder
125. The DSM-IV field trial for mixed anxiety-depression